Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ladostigil (Ladostigil free base) 是一种具有口服活性的胆碱酯酶和脑选择性单胺氧化酶(MAO)双重抑制剂,对 MAO-B 和 AChE 具有抑制作用,IC50值分别为37.1和31.8μM。Ladostigil 具有抗炎、抗氧化和神经保护活性,可用于研究抑郁症和阿尔茨海默病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 840 | 现货 | ||
5 mg | ¥ 2,030 | 现货 | ||
10 mg | ¥ 3,050 | 现货 | ||
25 mg | ¥ 4,920 | 现货 | ||
50 mg | ¥ 7,150 | 现货 | ||
100 mg | ¥ 9,630 | 现货 | ||
500 mg | ¥ 19,200 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,800 | 现货 |
产品描述 | Ladostigil (Ladostigil free base) is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO) with inhibitory effects on MAO-B and AChE, with IC50 values of 37.1 and 31.8 μM, respectively.Ladostigil possesses anti-inflammatory, antioxidant, and neuroprotective activities, and may be used in studies of depression and Alzheimer's disease. |
靶点活性 | AChE:31.8 μM, MAO-B:37.1 μM |
体外活性 |
Ladostigil (1-10 µM) demonstrates neuroprotective effects by preventing the decline in mitochondrial membrane potential (ψ), reducing apoptotic cascades, and inhibiting the production of reactive oxygen species (ROS) induced by OS insults.[6] Ladostigil (1-10 µM) exhibits notable neuroprotective effects in human neuroblastoma SK-N-SH cells. These effects involve the inhibition of caspase-3 activation, upregulation of Bcl-2 expression, and downregulation of Bad and Bax gene and protein expression.[6] |
体内活性 |
Ladostigil (17 mg/kg; p.o. daily for 6 weeks) eliminates hyperanxiety and depressive-like behavior in adulthood in rats exposed to prenatal stress, spanning from puberty to the adult stage. This effect is demonstrated in both the elevated plus maze (EPM) and forced swim tests (FST).[8] Ladostigil (50 μmol/kg; single p.o.) restores the loss of episodic memory in the object recognition test in rats.[7] |
别名 | TV-3326, Ladostigil, TV 3326, TV3326, Ladostigil free base |
分子量 | 272.34 |
分子式 | C16H20N2O2 |
CAS No. | 209394-27-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.8 mg/mL (17.63 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.6719 mL | 18.3594 mL | 36.7188 mL | 91.797 mL |
5 mM | 0.7344 mL | 3.6719 mL | 7.3438 mL | 18.3594 mL | |
10 mM | 0.3672 mL | 1.8359 mL | 3.6719 mL | 9.1797 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Ladostigil 209394-27-4 Metabolism Neuroscience oxidation-reduction Antioxidant MAO AChE TV-3326 TV 3326 TV3326 Ladostigil free base Inhibitor inhibitor inhibit